drugset / Trial / NCT00462046

Efficacy and Safety of Berberine in the Treatment of Diabetes With Dyslipidemia

NCT00462046

Phase 3 Completed 120 enrolled Shanghai Jiao Tong University School of Medicine
RandomizedFactorialDouble-blindTreatment

Summary

Berberine has showed effective in lowering blood sugar levels in db/db mice and anti-dyslipidemia in human. These findings have not been tested in a clinical trial. This randomized, double blind, placebo controlled and multi-center study has demonstrated that berberine is effective in lowering plasma glucose concentrations, reducing serum HbA1c and anti-dyslipidemia in type 2 diabetic patients with dyslipidemia.

Timeline

Start
2005-04
Primary completion
Completion
2006-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Berberine Traditional medicine (herbal / TCM) 1 g